Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

A novel germline NF1 splicing variant drives the onset of an anorectal mucosal melanoma in a patient with a stable and durable nivolumab response

Title: A novel germline NF1 splicing variant drives the onset of an anorectal mucosal melanoma in a patient with a stable and durable nivolumab response
Authors: Berrino E.; Bellomo S. E.; Mastorino L.; Morbidoni V.; Crosetto N.; Sapino A.; Sarotto I.; Chesta A.; Gianluca A.; Quaglino P.; Zampieri D.; Senetta R.; Trevisson E.; Marchio C.; Ribero S.
Contributors: Berrino, E.; Bellomo, S. E.; Mastorino, L.; Morbidoni, V.; Crosetto, N.; Sapino, A.; Sarotto, I.; Chesta, A.; Gianluca, A.; Quaglino, P.; Zampieri, D.; Senetta, R.; Trevisson, E.; Marchio, C.; Ribero, S.
Publisher Information: Pacini Editore srl
Publication Year: 2025
Collection: Padua Research Archive (IRIS - Università degli Studi di Padova)
Subject Terms: anorectal mucosal melanoma; low TMB; M1 macrophage; NF1 syndrome; nivolumab; PD-L1 negativity
Description: Objective: Neurofibromatosis type-1 (NF1) patients rarely develop mucosal melanomas. We report a rare form of anorectal mucosal melanoma (ARMM) in an NF1 syndromic patient profiled for genomics and transcriptomics to assess the determinants of the response to nivolumab. Methods: Primary melanoma and metastases were analyzed with targeted sequencing and gene expression profile (tGEP). We applied in silico (cBioPortal and predictor tools) and in vitro (hybrid minigene) approaches to confirm the variant pathogenicity. Results: We detected the novel c.4269+2_4269+3delTG germline splicing variant in NF1, which proved to be pathogenic by the minigene assay showing an aberrant splicing. The tumor showed a copy-number (CN) neutral loss of heterozygosity for the WT allele, and both ARMM and metastases carried several CN gains associated with NF1-driven carcinogenesis and very low mutation burden. The tGEP analysis unveiled a macrophagic infiltration, with a pro-inflammatory M1-type polarization, in the context of lack of PD-L1 expression. Conclusions: The response to nivolumab in a germline NF1-driven ARMM case seems independent from levels of TMB and PD-L1 expression and may be mediated by inflammatory response induced by M1-polarized macrophages.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/41243511; volume:117; issue:4; firstpage:423; lastpage:429; numberofpages:7; journal:PATHOLOGICA; https://hdl.handle.net/11577/3573598
DOI: 10.32074/1591-951X-N1157
Availability: https://hdl.handle.net/11577/3573598; https://doi.org/10.32074/1591-951X-N1157
Rights: info:eu-repo/semantics/openAccess ; license:Creative commons ; license uri:http://creativecommons.org/licenses/by-nc-nd/4.0/
Accession Number: edsbas.2A99AA62
Database: BASE